Homeopathic Respiratory Composition for Mucociliary Clearance

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for acute and chronic inflammatory and allergic respiratory diseases, particularly rhinosinusitis, are inadequate in effectively addressing inflammation, edema, and mucociliary clearance, often leading to chronicity and complications, and existing drugs may suppress ciliated epithelium function.

Innovation Solution

A homeopathic pharmaceutical composition comprising effective amounts of alcoholic tinctures of Euphrasia officinalis, Allium cepa, Arnica montana, and optionally Tartarus stibiatus, Hepar sulfur, and Apis mellifica, which synergistically enhance mucociliary clearance, anti-inflammatory, and restorative effects on the respiratory tract.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional treatments are used for inflammatory and allergic respiratory diseases, then symptom relief may be achieved, but mucociliary clearance is suppressed and ciliated epithelium function is impaired

Engineering Contradiction:
Improveeffectiveness of treatmentVSAvoidsuppression of ciliated epithelium function
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent changes the pharmacological parameters by using homeopathic dilutions (potencies) of natural substances, which alter the concentration and biological activity of active components to achieve therapeutic effects without suppressing ciliated epithelium function

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention uses composite homeopathic preparations containing multiple natural substances (e.g., Allium cepa, Euphrasia officinalis, Arnica montana, Apis mellifica, Tartarus stibiatus, Hepar sulfur) that work synergistically to treat respiratory diseases while preserving mucociliary clearance

Inventive Principle:
Principle #40Composite materials

2Reliability

If conventional anti-inflammatory drugs are used, then inflammation is reduced, but edema and mucosal damage persist

Engineering Contradiction:
Improveanti-inflammatory effectVSAvoidedema and mucosal damage
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent applies homeopathic substances with specific local effects on different aspects of inflammation: Allium cepa for mucosal inflammation, Arnica montana for edema, and Apis mellifica for allergic reactions, achieving comprehensive local treatment

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The invention converts the harmful effects of conventional anti-inflammatories (edema and mucosal damage) into beneficial effects by using homeopathic substances that specifically target and resolve these issues without causing harm

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Reliability

If multiple medications are combined to treat complex respiratory conditions, then therapeutic coverage is improved, but treatment complexity increases

Engineering Contradiction:
Improvetherapeutic coverageVSAvoidtreatment complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent merges multiple homeopathic substances into single preparation formulations that can be administered together, simplifying the treatment regimen while maintaining comprehensive therapeutic coverage for complex respiratory conditions

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The homeopathic preparations are designed to address multiple functions simultaneously: anti-inflammatory, anti-edematous, mucolytic, and restorative effects, providing universal treatment for various respiratory conditions

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20250295777A1Homeopathic pharmaceutical composition for treating upper and lower respiratory tract diseases
Publication Date: 2025.09.25 NERSESYAN MARINA VLADISLAVOVNA

AI summary

The invention relates to a pharmaceutical composition for treating or preventing acute and chronic inflammatory, allergic, post-traumatic, atrophic and hypertrophic diseases of the upper and lower respiratory tracts, and to the use thereof. The pharmaceutical composition comprises alcoholic tinctures of Tartarus stibiatus, Hepar sulfur, Euphrasia officinalis, Allium cepa and Arnica montana and an alcoholic solution of Apis mellifica, which are mixed with a physiologically acceptable carrier.